{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:46:03Z","timestamp":1770723963522,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jiac.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:23:06Z","timestamp":1569630186000},"page":"242-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study"],"prefix":"10.1016","volume":"26","author":[{"given":"Taiga","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-1696","authenticated-orcid":false,"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-824X","authenticated-orcid":false,"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0207-9483","authenticated-orcid":false,"given":"Yuichiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-6163","authenticated-orcid":false,"given":"Kazuhiro","family":"Tateda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Tomono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9628-9125","authenticated-orcid":false,"given":"Tadashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Niki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazui","family":"Soma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jiac.2019.08.018_bib1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.jiac.2019.08.018_bib2","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","article-title":"Pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"46","author":"Rubinstein","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.08-1357","article-title":"Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital","volume":"135","author":"Shindo","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2019.08.018_bib5","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2019.08.018_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/491708","article-title":"Vancomycin: a 50-year reassessment","volume":"42","author":"Moellering","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/38.5.865","article-title":"Penetration of vancomycin into human lung tissue","volume":"38","author":"Cruciani","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.08.018_bib8","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2019.08.018_bib9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2019.08.018_bib10","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2019.08.018_bib11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/430175","article-title":"Decreasing in\u00a0vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux","volume":"40","author":"Rhee","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S.\u00a0aureus (MRSA) blood isolates from 2001\u201305","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.08.018_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/ajrccm.161.3.9904115","article-title":"Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin\/dalfopristin versus vancomycin","volume":"161","author":"Fagon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00134-003-2135-y","article-title":"Linezolid in VAP by MRSA: a better choice?","volume":"30","author":"Ioanas","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2006-933677","article-title":"Methicillin-resistant S.\u00a0aureus ventilator-associated pneumonia: strategies to prevent and treat","volume":"27","author":"Lam","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib17","series-title":"Practical guidelines for the management and treatment of infections caused by MRSA (in Japanese)","year":"2019"},{"key":"10.1016\/j.jiac.2019.08.018_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2019.08.018_bib19","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2019.08.018_bib20","first-page":"S1","article-title":"Definition of hospital-acquired pneumonia and characteristics of guidelines in Japan","volume":"14","author":"Japanese Respiratory Society","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2019.08.018_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.resinv.2012.11.001","article-title":"Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]","volume":"51","author":"Kohno","year":"2013","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2019.08.018_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2019.08.018_bib23","first-page":"S4","article-title":"Establishment of new severity ratings based on analysis of hospital-acquired pneumonia","volume":"14","author":"Japanese Respiratory Society","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2019.08.018_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A\u00a0prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib25","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard. 9th edition. CLSI document M07-A9","year":"2012"},{"key":"10.1016\/j.jiac.2019.08.018_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diagmicrobio.2011.11.010","article-title":"Antimicrobial susceptibility and molecular characteristics of 857 methicillin-resistant Staphylococcus aureus isolates from 16 medical centers in Japan (2008\u20132009): nationwide survey of community-acquired and nosocomial MRSA","volume":"72","author":"Yanagihara","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s101560050020","article-title":"Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: report of the Committee for the Respiratory System, Japan Society of Chemotherapy","volume":"5","author":"Saito","year":"1999","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.08.018_bib28","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.06701-11","article-title":"Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus","volume":"50","author":"Haque","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2019.08.018_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131932","article-title":"Predictors of clinical success in the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) nosocomial pneumonia (NP)","volume":"10","author":"Shorr","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2019.08.018_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075171","article-title":"Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals","volume":"8","author":"Tadros","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2019.08.018_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2133\/dmpk.21.54","article-title":"Evaluation of clinical efficacy of Maeda's nomogram for vancomycin dosage adjustment in adult Japanese MRSA pneumonia patients","volume":"21","author":"MaedaY","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jiac.2019.08.018_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/ciq031","article-title":"Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens","volume":"52","author":"Rubinstein","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5649\/jjphcs.43.417","article-title":"Evaluation of the clinical course of methicillin-resistant Staphylococcus aureus infections in consideration of the efficacy of linezolid","volume":"43","author":"Hanai","year":"2017","journal-title":"Jpn J Pharm Health Care Sci"},{"key":"10.1016\/j.jiac.2019.08.018_bib34","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1155\/2013\/585834","article-title":"The impact of serum vancomycin levels and minimum inhibitory concentrations of methicillin-resistant Staphylococcus aureus on mortality in patients with nosocomial pneumonia","volume":"24","author":"Machado","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jiac.2019.08.018_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajem.2016.10.058","article-title":"Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: a retrospective cohort analysis: effectiveness of linezolid in the elderly","volume":"35","author":"Takada","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jiac.2019.08.018_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/cid\/cis332","article-title":"Should we abandon vancomycin for treatment of methicillin-resistant Staphylococcus aureus pneumonia? Still questions to answer","volume":"55","author":"Taccone","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/cid\/cir907","article-title":"Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues","volume":"54","author":"Torres","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.08.018_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214309","article-title":"The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: retrospective cohort study","volume":"14","author":"Yahav","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2019.08.018_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmi.2015.04.003","article-title":"Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis","volume":"21","author":"Steinmetz","year":"2015","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19302685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:42Z","timestamp":1761159582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19302685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1341321X19302685"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}